- Drug wholesaler McKesson's (MCK -23.2%) lackluster Q3 numbers and softer guidance due to pricing pressure is weighing on the entire drug supply chain. Competitors AmerisourceBergen (ABC -11.9%) and Cardinal Health (CAH -11.2%) report next week.
- Representative tickers: (ESRX -4.5%)(CVS -3.9%)(WBA -2.7%)(RAD -0.9%)(UNH +0.1%)
McKesson's woes bode ill for drug supply chain
Recommended For You
About MCK Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| MCK | - | - |
| McKesson Corporation | ||